Trials / Unknown
UnknownNCT03606733
Suprachoroidal Injection of Triamcinolone Acetonide Using Custom Made Needle to Treat Retinal Disorders
Suprachoroidal Injection of Triamcinolone Acetonide Using Custom Made Needle to Treat Macular Diseases and Non Infectious Posterior Uveitis
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Marashi Eye Clinic · Academic / Other
- Sex
- All
- Age
- 20 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
Injection in the Suprachoroidal space has potential of increasing the efficacy of the drug upto six times with direct effect on retinal tissues sparing the crystalline lens and trabecular meshwork.
Detailed description
A custom made 30 gauge needle offering 1000 micron penetration of the sclera at the parsplana with the help of gentle pressure on the sclera will help to inject medication such as triamcinilone or VEGF blockade agents (Ziv aflibercept or Bevacizumab) in the potential Suprachoroidal space which offers direct effect of injected drug on the retina and choroid sparing both crystalline lens, trabecular meshwork and other ocular tissues, hence improving efficacy of the drug upto six times and reduce potential complications such as cataract and glaucoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Custom suorachoroidal needle | Custom made Supra Choroidal Space needle |
Timeline
- Start date
- 2018-07-01
- Primary completion
- 2019-08-01
- Completion
- 2019-09-01
- First posted
- 2018-07-31
- Last updated
- 2018-10-29
Locations
1 site across 1 country: Syria
Source: ClinicalTrials.gov record NCT03606733. Inclusion in this directory is not an endorsement.